Paper32492417
Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer.
Becker LM and 16 others. Cell Rep, 2020. Cited by 250 papers, by iCite.
Cite this record
ConductScience Library. Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer. Papers, record 32492417. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32492417
- Cell line
- MDA-MB-231845 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cancer-Associated Fibroblasts | Major topic |
| Epigenomics | Major topic |
| Glucose | Major topic |
| Actins | |
| Animals | |
| Cell Line, Tumor | |
| Female | |
| Glycolysis | |
| Humans | |
| Hypoxia-Inducible Factor 1, alpha Subunit | |
| Lactic Acid | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Transgenic | |
| Monocarboxylic Acid Transporters | |
| Pyruvate Dehydrogenase Acetyl-Transferring Kinase | |
| Pyruvic Acid | |
| RNA Interference | |
| RNA, Small Interfering | |
| Symporters | |
| Monocarboxylate Transport Protein 1 |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| R01 CA125550 | NCI NIH HHS | United States | R01CA125550 | PubMed and NIH | NIH RePORTER |
| P01 CA120964 | NCI NIH HHS | United States | P01CA120964 | PubMed and NIH | NIH RePORTER |
| U01 CA235510 | NCI NIH HHS | United States | U01CA235510 | PubMed and NIH | NIH RePORTER |
| R01 CA155370 | NCI NIH HHS | United States | R01CA155370 | PubMed and NIH | NIH RePORTER |
| S10 OD012304 | NIH HHS | United States | S10OD012304 | PubMed and NIH | NIH RePORTER |
| P30 CA006516 | NCI NIH HHS | United States | P30CA006516 | PubMed and NIH | NIH RePORTER |
| T32 DK007760 | NIDDK NIH HHS | United States | T32DK007760 | PubMed | NIH RePORTER |
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27308568 | Metabolic rewiring in cancer-associated fibroblasts provides a niche for oncogenesis and metastatic dissemination. | Mol Cell Oncol | 2016 | https://conductscience.org/library/papers/27308568 | PubMed |
| 2 | 21620138 | Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. | Cell | 2011 | https://conductscience.org/library/papers/21620138 | PubMed |
| 3 | 28687621 | Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/28687621 | PubMed |
| 4 | 17106243 | Identification of fibroblast heterogeneity in the tumor microenvironment. | Cancer Biol Ther | 2006 | https://conductscience.org/library/papers/17106243 | PubMed |
| 5 | 24074532 | Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. | Hum Pathol | 2013 | https://conductscience.org/library/papers/24074532 | PubMed |
| 6 | 21558814 | Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21558814 | PubMed |
| 7 | 23475953 | Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor. | Mol Cancer Res | 2013 | https://conductscience.org/library/papers/23475953 | PubMed |
| 8 | 23999443 | Targeting lactate metabolism for cancer therapeutics. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23999443 | PubMed |
| 9 | 16423989 | Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. | Cancer Res | 2006 | https://conductscience.org/library/papers/16423989 | PubMed |
| 10 | 21249190 | Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. | PLoS One | 2011 | https://conductscience.org/library/papers/21249190 | PubMed |
| 11 | 26667266 | Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. | Nat Commun | 2015 | https://conductscience.org/library/papers/26667266 | PubMed |
| 12 | 23817022 | Origin and function of myofibroblasts in kidney fibrosis. | Nat Med | 2013 | https://conductscience.org/library/papers/23817022 | PubMed |
| 13 | 22083101 | Uncovering the role of 5-hydroxymethylcytosine in the epigenome. | Nat Rev Genet | 2011 | https://conductscience.org/library/papers/22083101 | PubMed |
| 14 | 26771115 | The Emerging Hallmarks of Cancer Metabolism. | Cell Metab | 2016 | https://conductscience.org/library/papers/26771115 | PubMed |
| 15 | 24856586 | Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24856586 | PubMed |
| 16 | 29883428 | Fibroblasts in the Tumor Microenvironment: Shield or Spear? | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29883428 | PubMed |
| 17 | 29991493 | Hidden features: exploring the non-canonical functions of metabolic enzymes. | Dis Model Mech | 2018 | https://conductscience.org/library/papers/29991493 | PubMed |
| 18 | 23860382 | Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery. | Cell Cycle | 2013 | https://conductscience.org/library/papers/23860382 | PubMed |
| 19 | 28447602 | Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. | Nat Commun | 2017 | https://conductscience.org/library/papers/28447602 | PubMed |
| 20 | 15882617 | Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. | Cell | 2005 | https://conductscience.org/library/papers/15882617 | PubMed |
Cited by200
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 250 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957652 | Cancer-associated fibroblasts: origins, functional heterogeneity and therapeutic potential. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42957652 | PubMed |
| 42864774 | Integrated scRNA-Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer-Associated Fibroblast-Dominant Domains in Colorectal Cancer. | Cancer Med | 2026 | https://conductscience.org/library/papers/42864774 | PubMed |
| 42859163 | Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42859163 | PubMed |
| 42801661 | Integrated Multi-Omics Reveals Cellular States and Microenvironmental Remodeling in Coexisting DCIS and IDC. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42801661 | PubMed |
| 42658371 | Lactate metabolism and protein lactylation in inflammatory and tumor microenvironments. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42658371 | PubMed |
| 42639447 | Metabolic heterogeneity and functional diversity of cancer-associated fibroblasts in gastric cancer (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42639447 | PubMed |
| 42638590 | Epigenetic mechanisms and clinical translation in ovarian cancer: from molecular pathways to precision therapy. | Biosci Rep | 2026 | https://conductscience.org/library/papers/42638590 | PubMed |
| 42540481 | Evaluating the potential causal relationship between carnitine-related metabolites and breast cancer: a Mendelian randomization and transcriptomic analysis. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42540481 | PubMed |
| 42536269 | Carbohydrates metabolic reprogramming and tumor microenvironment in pancreatic cancer: targeting pathways. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42536269 | PubMed |
| 42402629 | Protein lactylation in health and diseases: molecular mechanisms, biological significance, and clinical implications. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42402629 | PubMed |
| 42370534 | FOXO1 Is Required for Growth and Viability of Cancer-Associated Fibroblasts in Human Breast Carcinomas. | Genes Cells | 2026 | https://conductscience.org/library/papers/42370534 | PubMed |
| 42338603 | Glycolytic reprogramming in cancer: immune crosstalk, nutrient competition, and supportive care perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42338603 | PubMed |
| 42292442 | The role of the intratumoral microbiota in breast cancer metastasis and immune regulation: mechanisms and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292442 | PubMed |
| 42271411 | Glycolytic cancer-associated fibroblasts orchestrate metabolic remodeling in the tumor microenvironment. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42271411 | PubMed |
| 42228917 | Whole-transcriptome sequencing reveals hypoxic esophageal squamous cell carcinoma-derived migrasomes driving cancer-associated fibroblast activation. | Brief Funct Genomics | 2026 | https://conductscience.org/library/papers/42228917 | PubMed |
| 42192870 | Differential Protumoral Mechanisms Induced by CAFs in Cervical Cancer Cells Occur Independently of 17β-Estradiol Stimulation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42192870 | PubMed |
| 42152013 | Glycolysis-driven cancer-associated fibroblasts shape T-Cell exclusion via the CXCL16-CXCR6 Axis: a metabolic-chemokine mechanism in tumor immunity. | J Transl Med | 2026 | https://conductscience.org/library/papers/42152013 | PubMed |
| 42082274 | Cancer-associated fibroblast targeting therapies as a tool to enhance responses to radiotherapy and immunotherapy. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42082274 | PubMed |
| 41902481 | Cancer-Associated Fibroblasts Functions as Multifunctional Architects of the Tumor Stroma and Represent Emerging Therapeutic Vulnerabilities. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41902481 | PubMed |
| 41899399 | Tumorigenesis and Tumor Microenvironment in Lung Cancer. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899399 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32492417
GET https://conductscience.org/api/papers/v1/32492417/references?page=2